SCILEX Holding Company is committed to the development and commercialization of nonopioid pain management products. The company’s lead product is ZTlido® (lidocaine topical system) 1.8%, a revolutionary lidocaine patch FDA-approved for the treatment of neuropathic pain of post-herpetic neuralgia (PHN).